Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

65.04
-1.4600-2.20%
Post-market: 65.480.4400+0.68%17:49 EDT
Volume:3.36M
Turnover:218.29M
Market Cap:12.74B
PE:-18.23
High:66.41
Open:66.39
Low:63.70
Close:66.50
52wk High:93.42
52wk Low:52.75
Shares:195.81M
Float Shares:167.00M
Volume Ratio:1.19
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.06
PE(LYR):-17.18

Loading ...

BridgeBio initiated with a Buy at Canaccord

TIPRANKS
·
Jun 03

BridgeBio publishes corporate presentation outlining rare-disease pipeline and 2026 milestones

Reuters
·
Jun 03

BridgeBio price target raised to $98 from $94 at Morgan Stanley

TIPRANKS
·
May 28

BridgeBio Pharma Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
May 28

BridgeBio Pharma Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
May 28

Analysts Are Bullish on These Healthcare Stocks: Bristol-Myers Squibb (BMY), BridgeBio Pharma (BBIO)

TIPRANKS
·
May 28

BridgeBio announces FDA acceptance, priority review of BBP-418 NDA

TIPRANKS
·
May 27

BridgeBio Pharma Says FDA Accepts Muscular Dystrophy Drug Application for Priority Review

MT Newswires Live
·
May 27

BridgeBio says FDA accepts BBP-418 NDA for LGMD2I/R9, grants priority review

Reuters
·
May 27

BridgeBio Announces FDA Acceptance and Priority Review of Nda for Bbp-418 for Lgmd2i/R9

THOMSON REUTERS
·
May 27

BridgeBio Pharma Inc - FDA Sets Pdufa Target Action Date of November 27, 2026 for Bbp-418

THOMSON REUTERS
·
May 27

BridgeBio Pharma Inc - FDA Not Planning Advisory Committee Meeting for Bbp-418 Application

THOMSON REUTERS
·
May 27

BridgeBio CEO Neil Kumar sells BBIO shares worth $1.73 million

Reuters
·
May 27

BridgeBio Pharma Inc : Raymond James Cuts to Market Perform From Outperform

THOMSON REUTERS
·
May 26

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Reuters
·
May 26

BridgeBio Pharma (BBIO) Gets a Hold from Citi

TIPRANKS
·
May 20

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Cullinan Management (CGEM)

TIPRANKS
·
May 20

BridgeBio Pharma President, CFO Thomas Trimarchi disposes of USD 2.41 million shares

Reuters
·
May 20

BridgeBio director Randal W. Scott sells USD 655,873 in common shares

Reuters
·
May 20

BridgeBio Pharma Initiated at Neutral by Citigroup

Dow Jones
·
May 19